Revisi per 25 Desember 2024 14.23 sunting Muhammad Anas Sidik (bicara \| kontrib) 25.791 suntingan Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan ← Revisi sebelumnya		Revisi per 25 Desember 2024 14.25 sunting balikkan Muhammad Anas Sidik (bicara \| kontrib) 25.791 suntingan Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan Revisi selanjutnya →
Baris 106: }} '''Kaspofungin''' ([[Nama Generik Internasional\|INN]])<ref name="INN"/><ref>[http://www.emea.europa.eu/htms/human/epar/c.htm European Medicines Agency's list of authorised medicines for human use (C)] {{webarchive \|url=https://web.archive.org/web/20071017030749/http://www.emea.europa.eu/htms/human/epar/c.htm \|date=17 October 2007 }}</ref> adalah obat antijamur lipopeptida ~~dari~~yang dikembangkan oleh [[Merck & Co.]], Inc..<ref name="Fungicides, antiprotozoa agents, microbiocides">{{cite web \|title=Patent Covering Caspofungin \|url=https://patents.google.com/patent/US5378804?oq=5378804 \| access-date=18 March 2015}}</ref> ~~Caspofungin~~kaspofungin adalah penghambat pertama sintesis (1→3)-β-D-glukan jamur yang disetujui oleh [[Badan Pengawas Obat dan Makanan Amerika Serikat]].<ref name="Deresinski SC 2003 1445–1457">{{cite journal \| vauthors = Deresinski SC, Stevens DA \| title = Caspofungin \| journal = Clinical Infectious Diseases \| volume = 36 \| issue = 11 \| pages = 1445–57 \| date = June 2003 \| pmid = 12766841 \| doi = 10.1086/375080 \| doi-access = free }}</ref> ~~Caspofungin~~Kaspofungin diberikan secara [[infus\|intravena]].<ref name="Cancidas FDA label" /> Obat ini tercantum dalam [[Daftar Obat Esensial Organisasi Kesehatan Dunia]].<ref name="WHO23rd">{{cite book \| vauthors = ((World Health Organization)) \| title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) \| year = 2023 \| hdl = 10665/371090 \| author-link = World Health Organization \| publisher = World Health Organization \| location = Geneva \| id = WHO/MHP/HPS/EML/2023.02 \| hdl-access=free }}</ref>▼ ▲Caspofungin adalah penghambat pertama sintesis (1→3)-β-D-glukan jamur yang disetujui oleh Badan Pengawas Obat dan Makanan Amerika Serikat.<ref name="Deresinski SC 2003 1445–1457">{{cite journal \| vauthors = Deresinski SC, Stevens DA \| title = Caspofungin \| journal = Clinical Infectious Diseases \| volume = 36 \| issue = 11 \| pages = 1445–57 \| date = June 2003 \| pmid = 12766841 \| doi = 10.1086/375080 \| doi-access = free }}</ref> Caspofungin diberikan secara intravena.<ref name="Cancidas FDA label" /> Obat ini tercantum dalam Daftar Obat Esensial Organisasi Kesehatan Dunia.<ref name="WHO23rd">{{cite book \| vauthors = ((World Health Organization)) \| title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) \| year = 2023 \| hdl = 10665/371090 \| author-link = World Health Organization \| publisher = World Health Organization \| location = Geneva \| id = WHO/MHP/HPS/EML/2023.02 \| hdl-access=free }}</ref> ==Kegunaan dalam medis== ==Efek samping==

Kaspofungin: Perbedaan antara revisi